Newsroom

MAY 23, 2019 Glytec Goes Global, With Six New International Patent Allowances The digital therapeutics pioneer is expanding its intellectual property footprint beyond the U.S., gaining worldwide protections for its proprietary diabetes therapy management solutions. Waltham, MA — The rise in diabetes is truly a global phenomenon. The World Health Organization has been vocal about the estimated...

JUNE 29, 2017 Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Software Poised to address diabetes on a global scale, the company expands its intellectual property protections in the United States and abroad. WALTHAM, MA — Glytec, the healthcare company behind a market-leading software solution for personalized diabetes therapy management, announces five new...